26.05.2011
Aldrich Materials Science, a strategic growth initiative of Sigma-Aldrich, announced the establishment of a permanent endowment through the Materials Research Society (MRS) to support the new Mid-Career Researcher Award.
more30.03.2011
Mutual trust is at the heart of years, in some cases even decades, of personal relationships between Metrohm and many customers representing global brands from all kinds of industries. In a selection of short videos, some of these customers tell, how Metrohm has met their demand for custom solutions to challenges they faced in their laboratory.
The videos can be watched at www.metrohm.com
more03.02.2011
Sigma Life Science announced that its SAGE Labs initiative has partnered with Cofactor Genomics in an effort to sequence genomes for six of the most widely used strains of rat. As part of the agreement, Cofactor Genomics plans to generate and analyze sequence data using next generation sequencing systems, while SAGE Labs plans to provide the samples and to host a new, free public database at sageresearchmodels.com in late 2011. The database will include exclusive genomic information and analysis tools.
more01.12.2010
Aldrich Materials Science, a Sigma-Aldrich business, announced that it has expanded its capabilities for the preparation, processing and analysis of 'Hard Materials,' including ultra-high purity metals, metal salts, alloys and ceramics. The Company's site in Urbana, Illinois will serve as the Company's Hard Materials Center of Excellence.
more15.11.2010
Domainex, the Contract Research Organization committed to drug discovery,announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
http://www.domainex.co.uk/
more11.11.2010
SAFC, a member of the Sigma-Aldrich Group, announced an extension to Sigma-Aldrich's proprietary CompoZr Zinc Finger Nuclease (ZFN) platform that will expand the availability of ZFN-based technology to include off-the-shelf ZFNs and custom cell engineering services for use in the biopharmaceutical industry.
more06.10.2010
SAFC, a member of the Sigma-Aldrich Group announced that Mark Cassidy has been appointed Vice President of SAFC's Contract Manufacturing Services. Cassidy joined SAFC in January 2009 as Director of Global Sales and Marketing, responsible for SAFC's contract manufacturing sales worldwide, which encompassed small and large molecule capabilities. Cassidy was promoted to his new position on September 20, 2010, and is based at SAFC's Cambridge, UK, facility and reports to SAFC President, Gilles Cottier.
more02.09.2010
Sigma Life Science, the innovative biological products and research services business of Sigma-Aldrich announced the global release of a range of engineered mammalian cell lines. This new product range combines Sigma's proprietary CompoZr zinc finger nuclease (ZFN) technology with the Company's extensive experience in gene silencing, to offer innovative tools for drug discovery, compound screening and fundamental research applications.
more05.08.2010
Sigma-Aldrich announced it has entered into an agreement with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, and Boston University (BU) to develop methods to measure several potential biomarkers of atherosclerotic cardiovascular disease (CVD) using plasma samples from the NHLBI's Framingham Heart Study (FHS), one of the most prestigious clinical studies in medicine. Funding for the project is provided by the NHLBI to Sigma-Aldrich under a research subaward agreement with BU.
more